Lidocaine Hci and Epinephrine
alpha-Adrenergic Agonist
NADAC/unit
N/A
Active Shortage
3 Manufacturers
9 ANDAs
Lidocaine Hci and Epinephrine stimulates alpha-adrenergic receptors, used for nasal congestion, glaucoma, or ADHD.
Active Shortages
2012-02-22 Limited Supply Available. Next Delivery and Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company
2012-02-22 Shortage reported, Hospira, Inc., a Pfizer Company
2012-02-22 Shortage reported, Hospira, Inc., a Pfizer Company
2012-02-22 Shortage reported, Hospira, Inc., a Pfizer Company
2012-02-22 Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company
Generic Manufacturers
B BRAUN MEDICAL INCDEPROCO INCFRESENIUS KABI USA LLCHOSPIRA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
